LifeMD Inc's fundamentals are relatively healthy, and its growth potential is high.Its valuation is considered fairly valued, ranking 78/208 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 9.25.In the medium term, the stock price is expected to trend down.Despite a very weak market performance over the past month, the company shows strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
LifeMD Inc's Score
Industry at a Glance
Industry Ranking
78 / 208
Overall Ranking
190 / 4582
Industry
Healthcare Equipment & Supplies
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Analyst Rating
Based on
8
analysts
Buy
Current Rating
9.250
Target Price
+154.12%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
LifeMD Inc Highlights
StrengthsRisks
LifeMD, Inc. is a provider of virtual healthcare services and pharmacy services. The Company offers telemedicine, access to laboratory and pharmacy services, and specialized treatment across 200 conditions, including primary care, men’s and women’s health, mental health, and weight management. Its Telehealth platform is end-to-end virtual healthcare directly to consumers and through select enterprise partnerships. In addition, the Company is focused on developing its Rex MD product portfolio, which is primarily focused on asynchronous men’s healthcare, e-pharmacy solutions, and men’s hormonal health. The Company owns a vertically integrated, proprietary digital care platform, a 50-state affiliated medical group, a state-of-the-art affiliated compounding pharmacy, and a United States based patient care center.
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 78.48% year-on-year.
Fairly Valued
The company’s latest PE is -12.83, at a medium 3-year percentile range.
Institutional Buying
The latest institutional holdings are 24.14M shares, increasing 10.27% quarter-over-quarter.
LifeMD, Inc. is a provider of virtual healthcare services and pharmacy services. The Company offers telemedicine, access to laboratory and pharmacy services, and specialized treatment across 200 conditions, including primary care, men’s and women’s health, mental health, and weight management. Its Telehealth platform is end-to-end virtual healthcare directly to consumers and through select enterprise partnerships. In addition, the Company is focused on developing its Rex MD product portfolio, which is primarily focused on asynchronous men’s healthcare, e-pharmacy solutions, and men’s hormonal health. The Company owns a vertically integrated, proprietary digital care platform, a 50-state affiliated medical group, a state-of-the-art affiliated compounding pharmacy, and a United States based patient care center.
Ticker SymbolLFMD
CompanyLifeMD Inc
CEOSchreiber (Justin)
Websitehttps://lifemd.com/
FAQs
What is the current price of LifeMD Inc (LFMD)?
The current price of LifeMD Inc (LFMD) is 3.240.
What is the symbol of LifeMD Inc?
The ticker symbol of LifeMD Inc is LFMD.
What is the 52-week high of LifeMD Inc?
The 52-week high of LifeMD Inc is 15.840.
What is the 52-week low of LifeMD Inc?
The 52-week low of LifeMD Inc is 3.250.
What is the market capitalization of LifeMD Inc?
The market capitalization of LifeMD Inc is 150.93M.
What is the net income of LifeMD Inc?
The net income of LifeMD Inc is -21.99M.
Is LifeMD Inc (LFMD) currently rated as Buy, Hold, or Sell?
According to analysts, LifeMD Inc (LFMD) has an overall rating of Buy, with a price target of 9.250.
What is the Earnings Per Share (EPS TTM) of LifeMD Inc (LFMD)?
The Earnings Per Share (EPS TTM) of LifeMD Inc (LFMD) is -0.252.